These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6099877)

  • 1. Changes in CNS sensitivity to cannabinoids with repeated treatment: tolerance and auxoesthesia.
    Karler R; Calder LD; Turkanis SA
    NIDA Res Monogr; 1984; 54():312-22. PubMed ID: 6099877
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentylenetetrazol kindling in mice.
    Karler R; Murphy V; Calder LD; Turkanis SA
    Neuropharmacology; 1989 Aug; 28(8):775-80. PubMed ID: 2571101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
    Karler R; Borys HK; Turkanis SA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):105-9. PubMed ID: 6289137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the convulsant readiness of mice as affected by korazol].
    Kryzhanovskiĭ GN; Shandra AA
    Farmakol Toksikol; 1984; 47(2):16-9. PubMed ID: 6714397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):23-39. PubMed ID: 4438826
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between delta-9-tetrahydrocannabinol and kindling by electrical and chemical stimuli in mice.
    Karler R; Calder LD; Sangdee P; Turkanis SA
    Neuropharmacology; 1984 Nov; 23(11):1315-20. PubMed ID: 6098847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repeated electroconvulsive shocks (ECS) on subthreshold doses of some CNS stimulants.
    Mateenuddin M; Brahmapurikar MT; Sadre NL
    Arch Int Pharmacodyn Ther; 1980 Jul; 246(1):118-21. PubMed ID: 6108743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabinoids on cardiac microsomal CaATPase activity and calcium uptake.
    Collins FG; Haavik CO
    Biochem Pharmacol; 1979 Aug; 28(15):2303-6. PubMed ID: 159054
    [No Abstract]   [Full Text] [Related]  

  • 12. Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats.
    Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Taracha E; Skórzewska A; Lehner M; Bidziński A; Płaźnik A
    Brain Res Bull; 2009 Mar; 78(6):299-305. PubMed ID: 19026723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant properties of cannabidiol.
    Turkanis SA; Cely W; Olsen DM; Karler R
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):231-46. PubMed ID: 4850602
    [No Abstract]   [Full Text] [Related]  

  • 14. Marijuana: a research overview.
    Rinaldi L
    Alaska Med; 1994; 36(2):107-13. PubMed ID: 7943621
    [No Abstract]   [Full Text] [Related]  

  • 15. The cannabinoids as potential antiepileptics.
    Karler R; Turkanis SA
    J Clin Pharmacol; 1981; 21(S1):437S-448S. PubMed ID: 6975285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling.
    De Luca G; Di Giorgio RM; Macaione S; Calpona PR; Costantino S; Di Paola ED; Costa N; Rotiroti D; Ibbadu GF; Russo E; De Sarro G
    Pharmacol Biochem Behav; 2005 May; 81(1):47-53. PubMed ID: 15894063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticonvulsant activity of cannabinoids in seizure sensitive gerbils.
    Cox B; ten Ham M; Loskota WJ; Lomax P
    Proc West Pharmacol Soc; 1975; 18():154-7. PubMed ID: 1178662
    [No Abstract]   [Full Text] [Related]  

  • 20. The convulsive profile of Cicuta douglasii (water hemlock).
    Nelson RB; Cole FR
    Proc West Pharmacol Soc; 1976; 19():193-7. PubMed ID: 995987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.